Drugs / hu3S193
hu3S193
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT00084799 | Jul 2004 → Jan 2006 | small cell lung carcinoma | Ludwig Institute for Cancer Research | Completed | No outcome recorded |
| Phase 1 | NCT00006099 | Aug 2000 → Feb 2002 | ovarian cancer | Ludwig Institute for Cancer Research | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT00006046 | Jul 2000 → Oct 2001 | colorectal cancer | Ludwig Institute for Cancer Research | Terminated | No outcome recorded Stop: Enrollment |
| Phase 23 trials · 2 missed | ||||||
| Phase 2 | NCT01370239 | Nov 2013 → Oct 2015 | breast cancer | Cancer Institute of the State of São Paulo | Terminated | No outcome recorded |
| Phase 2 | NCT01137071 | Apr 2011 → Jun 2015 | fallopian tube cancer, ovarian cancer, peritoneum cancer | Recepta Biopharma | Terminated | Missed primary Stop: Enrollment |
| Phase 2 | NCT00617773 | May 2008 → Jun 2012 | fallopian tube cancer, ovarian cancer, primary peritoneal carcinoma | Recepta Biopharma | Completed | Missed primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hu3S193 | “This study aimed to evaluate the clinical benefit of the humanized anti-Lewis Y monoclonal antibody, hu3S193, in advanced hormone receptor-positive and Lewis Y-positive BC...” PMID 34644735 ↗ Oct 2021 |
| Known as | 111In-hu3S193 | “indium (111In) monoclonal antibody (mAb) hu3S193 (111In-hu3S193)” NCT00006099 ↗ |
| Known as | 3S193 | “A phase I trial of humanized 3S193 (hu3S193) with dosing up to 40 mg/m2 demonstrated tumor targeting without serious toxicities or the development of human anti-human antibodies.” PMID 17909358 ↗ Oct 20071“Phase I Study of Humanized 3S193 (Anti-Lewis-Y) Antibody in Patients With Advanced Colorectal Carcinoma” NCT00006046 ↗ |
| Modality | Monoclonal antibody | “monoclonal antibody hu3S193” NCT00006046 ↗ |
| Route | Intravenous | “infused intravenously” NCT00006046 ↗ |